Chemoinformaics analysis of 7-epi-.alpha.-eudesmol
| Molecular Weight | 222.372 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 11 |
| Exact Molecular Weight | 222.198 | nRing | 2 |
| Solubility: LogS | -3.278 | nHRing | 0 |
| Solubility: LogP | 4.331 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.667 |
| Synth | 4.007 |
| Natural Product Likeliness | 3.041 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.35 |
| MDCK | 0.0000132 |
| BBB | 0.884 |
| PPB | 0.954851 |
| VDSS | 1.504 |
| FU | 0.0416639 |
| CYP1A2-inh | 0.118 |
| CYP1A2-sub | 0.511 |
| CYP2c19-inh | 0.115 |
| CYP2c19-sub | 0.906 |
| CYP2c9-inh | 0.242 |
| CYP2c9-sub | 0.725 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.52 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.232 |
| CL | 10.126 |
| T12 | 0.145 |
| hERG | 0.011 |
| Ames | 0.004 |
| ROA | 0.018 |
| SkinSen | 0.179 |
| Carcinogencity | 0.079 |
| EI | 0.902 |
| Respiratory | 0.363 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.85917 |